Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;48(2):96-100.
doi: 10.4314/gmj.v48i2.7.

Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients

H O Olawumi  1 , D O Olanrewaju  2 , A O Shittu  1 , I A Durotoye  1 , A A Akande  3 , A Nyamngee  4
Affiliations

Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients

H O Olawumi et al. Ghana Med J. 2014 Jun.

Abstract

Background: Human immunodeficiency virus (HIV) and Hepatitis B virus (HBV) share similar routes of transmission making it possible for an individual to have a co-infection. HBV infection is well known to be a major cause of chronic liver diseases worldwide. The aim of this study was to determine the prevalence of HBV infection among HIV infected HAART naïve patients and investigate the effect of co-infection on CD4 count and liver function.

Study design: This was a hospital based descriptive cross sectional study of one hundred consecutive therapy-naive HIV-infected individuals. The CD4 count, Hepatitis B surface antigen. Serum albumin, total Protein, and liver enzymes were determined using standard techniques.

Results: The prevalence of HIV and HBV co-infection was 37%. The mean serum ALT and ALP were significantly higher in the co-infected patients (P-values <0.05). The mean CD4 count of the mono infected patients was significantly higher (p-value of 0.014). The mean serum ALT, AST and ALP of mono and coinfected patients with CD4 count<200/µl were significantly higher than those with count ≥ 200 cells/µl. (p-value of <0.01). The mean ALT and AST of the co infected patients and all patients with CD4 count <200 cells/µl were higher than the normal reference range.

Conclusion: Approximately one third of HIV positive patients had hepatitis B virus co-infection. Co-infection and CD4 count <200 cells/µl are likely to result in abnormal ALT and AST. We recommend those co-infected patients and those with CD4 count <200 cells/µl should be given non-hepatotoxic antiretroviral drug.

Keywords: CD4 count; HIV; Hepatitis B; co-infection; liver function.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Similar articles

See all similar articles

Cited by

References

    1. Alter MJ. Epidemiology of viral hepatitis and HIV co infection. J Hepatol. 2006;44(1 Suppl):S6–S9. - PubMed
    1. Lee HC, Ko NY, Lee NY, et al. Seroprevalence of viral hepatitis and sexuallytransmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000–5: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc. 2008;107:404–411. - PubMed
    1. Diop-Ndiaye H, Toure-Kane C. Hepatitis B, C seroprevalence and deltavirus in HIV-1 Senegalese patients at HAART initiation (retrospective study) J Med Virol. 2008;80:1332–1336. - PubMed
    1. Nyirenda M, Beadsworth MB, Stephany P, et al. Prevalence of infection with hepatitis B and C virus and co infection with HIV in medical inpatients in Malawi. J Infect. 2008;57:72–77. - PubMed
    1. Puoti M, Torti C, Bruno R, et al. Natural history of chronic hepatitis B in co-infected patients. J Hepatol. 2006;44:65–70. - PubMed